Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease
暂无分享，去创建一个
C. Ruppert | S. Ciesek | A. Zeiher | S. Dimmeler | J. Cinatl | C. Spinner | A. Berkowitsch | A. Hansen | T. Eschenhagen | D. Bojkova | J. Vehreschild | F. Hanses | G. Luxán | S. Dolff | S. Borgmann | A. Guenther | S. Rieg | J. Wagner | M. Stecher | S. Cremer | G. S. Aslan | L. Pilgram | M. Rüthrich | Martina Haselberger | C. Piepel | K. Wille | M. Shumliakivska | H. Heuzeroth | A. Hansen | A. Hansen